J DIABETES RES 润色咨询

Journal of Diabetes Research

出版年份:暂无数据 年文章数:2018 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:3.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2023-12-01 ms3000000795637810 来自江苏省

    审稿速度:24.0 | 投稿命中率:75.0
    经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2023-08-27 ms8000002057789160 来自江苏省

    偏重的研究方向:糖尿病
    经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-03-05 nimeide123

    投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2023-02-11 ms8000000834758423 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:糖尿病;临床
    经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2023-01-15 ms8000001945466546 来自江苏省

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-09-28 我很焦急

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2021-12-02 Lijx1367

    5个月后告诉你找不到审稿人

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-02-09 wkw0722

    可以共通讯吗

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-04-28 ms5000001070060621

    偏重的研究方向:脑;糖尿病;临床
    经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2172289, encodeId=14bc21e228969, content=审稿速度:24.0 | 投稿命中率:75.0<br>经验分享:一审将近5个月,意见回来小修,修改提交后4个月了没消息,发邮件问说找不到review。。。再也不投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4975729351, createdName=ms3000000795637810, createdTime=Fri Dec 01 11:05:13 CST 2023, time=2023-12-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154784, encodeId=ec172154e84fc, content=偏重的研究方向:糖尿病<br>经验分享:求求大家不要投这个杂志,等了一个月都没有分学术编辑,幸好及时撤稿。最离谱的杂志 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8598441, createdName=ms8000002057789160, createdTime=Sun Aug 27 11:48:46 CST 2023, time=2023-08-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199695, encodeId=f0f711996951b, content=投稿两个月没动静,发邮件撤稿,同意,改投。结果又过了两个月来个审稿意见,小修。直接拒绝修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/c06abf4cec63a49eacb0ac6e07f0bcf6.jpg, createdBy=3ffb40995, createdName=nimeide123, createdTime=Sat Mar 05 17:10:53 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114127, encodeId=8798211412e6d, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病;临床<br>经验分享:2022年9月下旬投的一篇meta分析 2022年12月下旬给了大修 修完后1月下旬发回 2月上旬直接接收了 总体编辑还可以,reviewer意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec488146048, createdName=ms8000000834758423, createdTime=Sat Feb 11 16:24:51 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110296, encodeId=ac412110296c0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:2022.8.24投稿,一直AE invited,半个月前催了一次,然后三天前被撤稿了,说找不到审稿人。。。。太坑了!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ba15449837, createdName=ms8000001945466546, createdTime=Sun Jan 15 12:37:01 CST 2023, time=2023-01-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2090760, encodeId=60e32090e6092, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投稿2个月,还在AE INVITED,真慢,考虑撤稿了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4635207284, createdName=我很焦急, createdTime=Wed Sep 28 08:01:22 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076339, encodeId=91a310e6339b4, content=5个月后告诉你找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211202/91aa9390b9724e9b8fec658e372334af/ded8019134da4d988b474946a2695c55.jpg, createdBy=71262764624, createdName=Lijx1367, createdTime=Thu Dec 02 21:43:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191484, encodeId=8f1611914840f, content=可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Wed Feb 09 18:07:52 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215318, encodeId=0e501215318d1, content=偏重的研究方向:脑;糖尿病;临床<br>经验分享:****:4.011 Q3 投稿时间2022-04-19 等待分配编辑中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=ms5000001070060621, createdTime=Thu Apr 28 15:01:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230627, encodeId=073e123062e92, content=二修后pending approval大概要持续多久呀?有可能被拒吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Tue Jul 05 09:26:25 CST 2022, time=2022-07-05, status=1, ipAttribution=)]
    2022-07-05 wkw0722

    二修后pending approval大概要持续多久呀?有可能被拒吗?

    0

共89条页码: 1/9页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分